Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGamma Communications Regulatory News (GAMA)

Share Price Information for Gamma Communications (GAMA)

Share Price is delayed by 15 minutes
Get Live Data
962.00    8.00 (0.84%)
Bid:
961.50
Ask:
963.00
Spread: 1.50 (0.156%)
Market Cap: £868.34m
GAMA Live PriceLast checked at - London Stock Exchange

Intraday Gamma Communications Share Chart

Trading Statement

13 Jul 2021 07:00

RNS Number : 9733E
Gamma Communications PLC
13 July 2021
 

Tuesday 13 July

Gamma Communications plcPre-close trading update

Continued growth in first half

Gamma Communications plc ("Gamma" or the "Group"), a leading provider of Unified Communications as a Service ("UCaaS") to the business markets in the UK, Germany, Spain, and the Netherlands, is pleased to announce a trading update for the six months ended 30 June 2021. This is an update to the statement made at the time of the AGM on 20 May 2021.

Group overview

We are pleased to report that the Group has continued to perform well through the first six months of the year. Growth in the first half has been in line with the rate associated with market expectations for the full year. This is despite the first half again being characterised by lock downs in all of our territories which restricted sales activities for both Gamma and our partners. 

In both the UK and Europe, our financial model has continued to be robust given that over 90% of revenue is recurring and billed monthly. Cancellations of existing contracts continue to be at very low levels and bad debt remains negligible.

United Kingdom

In our UK Indirect business, net additions across all UCaaS products have been positive and in line with the previous period.

The performance of the UK Direct business is slightly ahead of our expectations. Growth has been closer to that of previous years despite the lower order intake during the first lockdown period in 2020. We have been awarded several new contracts during the period, including The Berkeley Group (Cloud Contact Centre and UCaaS), RSM (MS Teams) and The Royal Berkshire NHS Trust (SIP)

Overseas: Netherlands, Spain and Germany

Despite the markets being at a relatively early stage of their development, each of our overseas businesses continues to grow its Cloud seat base. This has been coupled with positive net growth of both SIP and Mobile. Despite some difficult COVID-19 related market conditions, the overall performance of our overseas business has been in line with our expectations.

Product development

We have successfully launched a number of key products in the UK, some of which were demonstrated at our recent Capital Markets Day. These include Phone Line + (a replacement service for customers who currently use basic telephone services) and Horizon Contact (our fully integrated Cloud Contact Centre solution). Phone Line + was developed by our recent acquisition, Mission Labs, and Horizon Contact was developed by the team at Telsis (which we acquired in late 2019). We have also launched our new mobile service in partnership with Three UK.

We are very pleased with our continued new product development and, by the end of July, all Gamma customers will have the option to fully integrate their Horizon Cloud service with Microsoft Teams. This option will enable Microsoft Teams users to be able to make and receive calls from their desktop as they would have done previously with a traditional phone.

Corporate activity

On 3 March 2021, the Group acquired Mission Labs Limited for £40.2m (on a cash free basis) with up to an additional £6.0m contingent deferred consideration payable over the next three years. Integration of the business has gone well and its early performance has been slightly ahead of expectations.

We continue to actively appraise acquisition targets in Europe to gain scale and to strengthen capabilities.

Cash

Gamma continues to have a very robust balance sheet, with strong cash generation from its trading activities which were in line with previous levels. Closing net cash at the half year is approximately £25.4m compared to £48.0m at the end of the previous year - the strong generation of cash from trading being offset by the acquisition of Mission Labs for £40.2m and a further payment of £5.0m in respect of our acquisition of HFO in 2020.

Outlook

Current management expectations for the full year ending 31 December 2021 are that results will be in the upper half of market consensus estimates.*

The Board expects to announce results for the half year ended 30 June 2021 on Tuesday 8 September 2021.

 

Andrew Taylor, Chief Executive, commented on the results:

"Despite the ongoing COVID-19 related difficulties across the UK and Europe, I am encouraged by our performance in the first half of 2021. All of our staff have continued to work incredibly hard to keep the business running remotely and our ongoing support of partners and customers has been excellent throughout the period. I am pleased with the development of our UCaaS strategy both organically and through the acquisition of Mission Labs, and with the release of an exciting range of new UCaaS products, including Phone Line Plus and Horizon Contact. I am delighted to welcome all of our new colleagues from Mission Labs into the Gamma family and I am pleased to see the continued growth of Circle Loop and Smart Agent (being the new products we gained as part of the acquisition)."

 

* The Company understand the range of market estimates for the year ending 31 December 2021 to be as follows: -

· Revenue £442.4m - £460.0m;

· Adjusted EBITDA £86.0m - £95.0m; and

· Adjusted EPS 54.9p - 63.1p.

 

Gamma Communications plc Tel: +44 (0) 333 006 5972

Andrew Taylor, Chief Executive Officer

Andrew Belshaw, Chief Financial Officer

Tulchan Communications LLP Tel: +44 (0) 207 353 4200

James Macey White

Matt Low

Investec Bank plc (NOMAD & Broker) Tel: +44 (0) 207 597 5970

Patrick Robb

Virginia Bull

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFZGMNDZMGMZM
Date   Source Headline
5th Dec 20257:00 amRNSAppointment of Joint Corporate Broker
4th Dec 20254:51 pmRNSHolding(s) in Company
18th Nov 20255:02 pmRNSDirector/PDMR Shareholding
12th Nov 20259:51 amRNSDeparture of Chief Financial Officer
10th Nov 20252:00 pmRNSHolding(s) in Company
3rd Nov 20254:21 pmRNSTotal Voting Rights
12th Sep 202511:29 amRNSHolding(s) in Company
9th Sep 20257:00 amRNSHalf-year Report
1st Sep 20258:59 amRNSTotal Voting Rights
1st Aug 20259:55 amRNSTotal Voting Rights
1st Jul 20251:29 pmRNSTotal Voting Rights
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20253:32 pmRNSHolding(s) in Company
12th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20251:28 pmRNSTotal Voting Rights
30th May 20257:00 amRNSTransaction in Own Shares
29th May 202511:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSDirector/PDMR Shareholding
15th May 20251:35 pmRNSHolding(s) in Company
15th May 202510:50 amRNSHolding(s) in Company
15th May 202510:15 amRNSResults of AGM
15th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSAGM trading update
7th May 20255:39 pmRNSHolding(s) in Company
6th May 20252:58 pmRNSDirector/PDMR Shareholding
2nd May 20258:00 amRNSReadmission - Gamma Communications plc
2nd May 20257:00 amRNSAdmission to trading on the Main Market
1st May 20253:14 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNSTransaction in Own Shares
29th Apr 20256:00 pmRNSGamma Communications
25th Apr 202512:00 pmRNSPublication of Prospectus
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20255:41 pmRNSHolding(s) in Company
15th Apr 20255:39 pmRNSHolding(s) in Company
15th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.